Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.

Singh AK, Maurya AK, Kant S, Umrao J, Kushwaha RA, Nag VL, Dhole TN.

J Postgrad Med. 2013 Jul-Sep;59(3):179-85. doi: 10.4103/0022-3859.118034.

2.

Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.

Said HM, Kock MM, Ismail NA, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

Int J Tuberc Lung Dis. 2012 Jan;16(1):104-9. doi: 10.5588/ijtld.10.0600.

PMID:
22236854
3.
4.

The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.

Theron G, Peter J, Richardson M, Barnard M, Donegan S, Warren R, Steingart KR, Dheda K.

Cochrane Database Syst Rev. 2014 Oct 29;(10):CD010705. doi: 10.1002/14651858.CD010705.pub2. Review.

5.

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W.

J Clin Microbiol. 2010 May;48(5):1683-9. doi: 10.1128/JCM.01947-09. Epub 2010 Mar 24.

6.

Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide testing by MTBDRsl in Armenia.

Margaryan H, Farnia P, Hayrapetyan A, Mirzoyan A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S159-S160. doi: 10.1016/j.ijmyco.2016.07.010. Epub 2016 Aug 12.

7.

Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa.

Gardee Y, Dreyer AW, Koornhof HJ, Omar SV, da Silva P, Bhyat Z, Ismail NA.

J Clin Microbiol. 2017 Mar;55(3):791-800. doi: 10.1128/JCM.01865-16. Epub 2016 Dec 14.

8.

Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Surcouf C, Heng S, Pierre-Audigier C, Cadet-Daniel V, Namouchi A, Murray A, Gicquel B, Guillard B.

BMC Infect Dis. 2011 Sep 28;11:255. doi: 10.1186/1471-2334-11-255.

9.

First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant Mycobacterium tuberculosis in Saudi Arabia.

Varghese B, Al-Hajoj S.

Am J Trop Med Hyg. 2017 May;96(5):1066-1070. doi: 10.4269/ajtmh.16-0579.

PMID:
28500800
10.

Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.

Jin J, Shen Y, Fan X, Diao N, Wang F, Wang S, Weng X, Zhang W.

J Mol Diagn. 2013 Jan;15(1):44-50. doi: 10.1016/j.jmoldx.2012.08.004. Epub 2012 Nov 15.

PMID:
23159109
11.

Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.

Perdigão J, Macedo R, Malaquias A, Ferreira A, Brum L, Portugal I.

J Antimicrob Chemother. 2010 Feb;65(2):224-7. doi: 10.1093/jac/dkp452. Epub 2009 Dec 22.

PMID:
20028780
12.

Performance of the MTBDRsl assay in Georgia.

Tukvadze N, Bablishvili N, Apsindzelashvili R, Blumberg HM, Kempker RR.

Int J Tuberc Lung Dis. 2014 Feb;18(2):233-9. doi: 10.5588/ijtld.13.0468.

13.

First evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrA.

Aubry A, Sougakoff W, Bodzongo P, Delcroix G, Armand S, Millot G, Jarlier V, Courcol R, Lemaître N.

PLoS One. 2014 Apr 17;9(4):e95083. doi: 10.1371/journal.pone.0095083. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113219.

14.

Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.

Brossier F, Guindo D, Pham A, Reibel F, Sougakoff W, Veziris N, Aubry A.

J Clin Microbiol. 2016 Jun;54(6):1573-80. doi: 10.1128/JCM.00051-16. Epub 2016 Apr 6.

16.

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study.

Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjö M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM.

J Clin Microbiol. 2015 Sep;53(9):2961-9. doi: 10.1128/JCM.01257-15. Epub 2015 Jul 15.

17.

Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Ignatyeva O, Kontsevaya I, Kovalyov A, Balabanova Y, Nikolayevskyy V, Toit K, Dragan A, Maxim D, Mironova S, Kummik T, Muntean I, Koshkarova E, Drobniewski F.

J Clin Microbiol. 2012 May;50(5):1593-7. doi: 10.1128/JCM.00039-12. Epub 2012 Feb 29.

18.

Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.

Barnard M, Warren R, Gey Van Pittius N, van Helden P, Bosman M, Streicher E, Coetzee G, O'Brien R.

Am J Respir Crit Care Med. 2012 Dec 15;186(12):1298-305. doi: 10.1164/rccm.201205-0960OC. Epub 2012 Oct 18.

PMID:
23087027
19.

[Conventional and molecular diagnosis in a group of patients with drug-resistant tuberculosis].

Mindru R, Spînu V, Popa C, Botezatu E, Spătaru R.

Pneumologia. 2014 Jul-Sep;63(3):168-73. Romanian.

PMID:
25420292
20.

Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.

Feng Y, Liu S, Wang Q, Wang L, Tang S, Wang J, Lu W.

PLoS One. 2013;8(2):e55292. doi: 10.1371/journal.pone.0055292. Epub 2013 Feb 1. Review.

Supplemental Content

Support Center